Compare QH & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QH | PMI |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | China | United States |
| Employees | N/A | 75 |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 14.1M |
| IPO Year | 2019 | N/A |
| Metric | QH | PMI |
|---|---|---|
| Price | $3.42 | $0.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 155.8K | ★ 35.4M |
| Earning Date | 04-02-2026 | 06-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.11 |
| 52 Week High | $10.85 | $13.68 |
| Indicator | QH | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 58.61 | 51.05 |
| Support Level | $0.46 | $0.11 |
| Resistance Level | $7.76 | $0.40 |
| Average True Range (ATR) | 0.71 | 0.05 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 31.84 | 72.33 |
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.